Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (85)	10/23/2002 11:32:46 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

BSX Is making another 52 wks H today after announcing that its 3 Q income more than doubled and that sales of its Express2 stent has more than tripled in its first few weeks since it was approved in the United States last month. It seems JNJ will have to wait for it to start selling its coated Cypher catheter in the U.S. in the 1st Q of 2003 <g> siliconinvestor.com siliconinvestor.com JNJ Is not doing so good just now.<g> siliconinvestor.com But watch for possible buying JNJ around the 56 level, since it should start doing better early next year.<g> siliconinvestor.com Bernard